The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Fusion-positive early-stage and locally advanced lung cancers: A real-world analysis of event-free, disease-free, and overall survival.
 
Sameh Daher
Honoraria - AstraZeneca; Bristol-Myers Squibb Israel; Merck Serono; Pfizer; Roche; Takeda
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - Roche
 
Jaime Rubio Perez
Consulting or Advisory Role - AstraZeneca; Takeda
Speakers' Bureau - AstraZeneca; LEO Pharma; MSD; Pfizer; Takeda
 
Matteo Repetto
Consulting or Advisory Role - OncLive/MJH Life Sciences
Travel, Accommodations, Expenses - Sanofi
 
Jamie Chaft
Consulting or Advisory Role - AstraZeneca/MedImmune; Boehringer Ingelheim; Exact Sciences; Foundation Medicine; Genentech/Roche; Lilly; Merck; Natera; Nuvation Bio; Revolution Medicines
Research Funding - AstraZeneca/MedImmune (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst)
(OPTIONAL) Uncompensated Relationships - AstraZeneca; Boehringer Ingelheim; Lilly; Merck
 
Soo-Ryum Yang
Honoraria - AstraZeneca; Medical Learning Institute; Medscape; OncLive/MJH Life Sciences; Prime Education; Roche
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; InVitae; Lilly; Merus; Revolution Medicines; Sanofi
(OPTIONAL) Uncompensated Relationships - Boehringer Ingelheim; Loxo/Lilly
 
Jason Chang
No Relationships to Disclose
 
Sabrina Lin
No Relationships to Disclose
 
Alexia Iasonos
Stock and Other Ownership Interests - Bristol-Myers Squibb/Sanofi
Consulting or Advisory Role - Bristol Myers Squibb; Intelligencia
 
Alexander Drilon
Stock and Other Ownership Interests - mBrace; Treeline Biosciences
Honoraria - Answers in CME; AstraZeneca; Bristol Myers Squibb Foundation; Clinical Care Options/NCCN; i3 Health; Ignyta/Genentech/Roche; Liberum; Loxo/Bayer/Lilly; OncLive/MJH Life Sciences; PER; Remedica; Research to Practice
Consulting or Advisory Role - Anheart Therapeutics; Axis Pharma; Bayer; Boundless Bio; Clinical Care Options; EcoR1 Capital; EMD Serono/Merck; Journal of the National Comprehensive Cancer Network; Liberum; Lilly; Med Learning; Medscape; Melendi; Monte Rosa Therapeutics; MORE Health; Novartis; Nuvalent, Inc.; Ology Medical Education; PeerView; Repare Therapeutics; touchIME; Treeline Biosciences; Zymeworks
Patents, Royalties, Other Intellectual Property - Osimertinib Selpercatinib; Wolters Kluwer (Royalties for Pocket Oncology)
Other Relationship - Anheart Therapeutics (Inst); Bayer (Inst); Boundless Bio (Inst); Bristol Myers Squibb Foundation (Inst); Exelixis (Inst); Lilly (Inst); Nuvalent, Inc. (Inst); Pfizer (Inst); Regeneron (Inst); Roche/Genentech (Inst); Triana (Inst)